Meet Lunit at ECR 2026
Hall Expo 1, Booth AI-10
AI that supports radiologists across chest X-ray and mammography
Discover our AI solutions, live at ECR
Experience how Lunit’s clinically validated AI solutions support radiologists in daily practice; enhancing cancer detection, improving workflow efficiency, and enabling confident decision-making.
Breast imaging:
Lunit INSIGHT Breast Suite (MMG/DBT)
An AI solution designed to support breast cancer detection in 2D mammography and 3D tomosynthesis by highlighting malignant lesions.

Chest radiology:
Lunit INSIGHT CXR
Lunit INSIGHT CXR is a workflow-oriented AI designed to support safer and more efficient review of chest X-rays by combining abnormality detection with high-confidence normal flagging.

Don't miss these hands-on workshops on AI in breast imaging
📍 House of FUJIFILM
Hands-on clinical case review with Dr. Claudia Kurtz (Lucerne Hospital, Switzerland)
Session 2: March 5 | 14:00–15:00
Hands-on clinical case review with Dr. Sergej Popovich (Evidia, Germany)
Session 3: March 6 | 15:30–16:30
Hands-on clinical case review with Dr. Karin Dembrower (Capio St Göran Hospital, Sweden)
Symposium: AI in breast imaging: already a success story or still a novel to write?
📍 House of FUJIFILM | March 7, 09:30 - 11:00
Speakers: Prof. Francesco Sardanelli, Dr Claudia Weiss, Dr. Sergej Popovich, Dr. Karin Dembrower
This symposium gathers seasoned experts to share diverse experiences on adopting AI systems in clinical and screening mammography throughout Europe. Attendees will gain insights into the current successes, challenges, and future directions of AI applications in this critical area of healthcare.
See the clinical evidence behind Lunit AI at ECR 2026
Explore how Lunit AI is shaping the future of breast imaging and chest radiology through peer-reviewed clinical research presented at ECR 2026. Across 15 accepted abstracts, Lunit solutions demonstrate advances in areas such as early cancer detection, workflow efficiency, risk stratification, or large-scale clinical deployment.
Lunit INSIGHT MMG/DBT
Early Detection and Interval Cancer
• Artificial intelligence reveals early mammographic signs of breast cancers diagnosed at subsequent screening
Di Gaetano et al. | Oral | RPS 1102 | March 5, 16:30-18:00